| aspsirna2255 |
UUGGAGACUUGCGCAAUGU
AACCUCUGAACGCGUUACA |
95 |
75 |
20 |
SOD1 |
Amyotrophic Lateral Sclerosis (ALS) |
c.256G>C,p.Gly86Arg |
rs12191243 |
|
US2007/0259827A1 |
| aspsirna2284 |
UUGGAGACUUGCGCAAUGU
AACCUCUGAACGCGUUACA |
70 |
20 |
50 |
SOD1 |
Amyotrophic Lateral Sclerosis (ALS) |
c.256G>C,p.Gly86Arg |
rs12191243 |
|
US2007/0259827A1 |
| aspsirna2322 |
UUGGAGACUUGCGCAAUGU
AACCUCUGAACGCGUUACA |
NA |
NA |
50 |
SOD1 |
Amyotrophic Lateral Sclerosis (ALS) |
c.256G>C,p.Gly86Arg |
rs12191243 |
|
US2007/0259827A1 |
| aspsirna2428 |
AACUCCUCCGCCCAACUUU
UUGAGGAGGCGGGUUGAAA |
15 |
70 |
-55 |
KRAS |
NA |
NA |
NA |
|
US007576197B2 |
| aspsirna0955 |
UCUUAAUGAUACAUUAGCU
AGAAUUACUAUGUAAUCGA |
90 |
45 |
45 |
KRT12 |
Meesmann epithelial corneal dystrophy (MECD) |
c.404G>C,p.Arg135Thr |
rs57218384 |
|
23233254 |
| aspsirna3516 |
UCUUAAUGAUACAUUAGCU
AGAAUUACUAUGUAAUCGA |
90 |
45 |
45 |
KRT12 |
Meesmann epithelial corneal dystrophy (MECD) |
c.404G>C,p.Arg135Thr |
rs57218384 |
|
23233254 |
| aspsirna0712 |
UUGGAGACUUGCGCAAUGU
AACCUCUGAACGCGUUACA |
81 |
32 |
49 |
SOD1 |
Amyotrophic Lateral Sclerosis (ALS) |
c.256G>C, p.Gly86Arg |
rs12191243 |
|
16965178 |
| aspsirna0732 |
UUGGAGACUUGCGCAAUGU
AACCUCUGAACGCGUUACA |
81 |
32 |
49 |
SOD1 |
Amyotrophic Lateral Sclerosis (ALS) |
c.256G>C, p.Gly86Arg |
rs12191243 |
|
16965178 |
| aspsirna0908 |
GGUUUACUCACCUCAUCCA
CCAAAUGAGUGGAGUAGGU |
70 |
NA |
NA |
B2M |
HLA incompatibility |
c.31G>C,p.Ala11Pro |
rs10489448 |
|
16520945 |
| aspsirna0920 |
GGUUUACUCACCUCAUCCA
CCAAAUGAGUGGAGUAGGU |
70 |
NA |
NA |
B2M |
HLA incompatibility |
c.31G>C,p.Ala11Pro |
rs10489448 |
|
16520945 |
| aspsirna3760 |
AAAGUUGCGCGGAGGAGUU
UUUCAACGCGCGUCCUCAA |
90 |
40 |
50 |
PPIB/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
NA |
NA |
|
16489337 |
| aspsirna0944 |
AUGUCCAUCCACCAGCAGC
UACAGGUAGGUGGUCGUCG |
86 |
32 |
54 |
AR |
Spinal and Bulbar Muscular Atrophy, X-linked 1; SMAX1/Kennedy’s disease |
c.172_174CAG(10_36) (p.Gln69_Gln80del)] |
rs19392293 |
|
11809726 |
